Product Information
JNJ-17203212 is a potent, selective inhibitor of TRPV1 cation channels. It blocks the entry of calcium ions into cells by binding to the channel and blocking the ion passage. JNJ-17203212 has been shown to inhibit chronic cough symptoms in animal models, as well as decrease the amount of mucus produced in response to capsaicin or citric acid. This drug also has potential for treating bone cancer, inflammatory bowel disease (IBD), and diabetes-induced neuropathy. JNJ-17203212 is not expected to be effective for obesity because it does not affect body mass index.
Chemical properties
Technical inquiry about: 3D-WHB76806 JNJ-17203212
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
